0 |
CKD, Post On PCABS Renal Function |
223 |
5 |
US, Brazil |
I |
CKD, Post On PCABS Renal Protection Agent |
30 |
1 |
US |
II |
Renal Biomarker |
32 |
6 |
US |
II |
End-Stage Kidney Disease |
79 |
14 |
US |
II |
CKD, Post On PCABS Renal Protection Agent |
310 |
25 |
US |
II |
Microalbuminuria, Hypertension, Type 2 Diabetes |
420 |
90 |
US |
II |
Hyperuricemia, Renal Impairment, Gout |
240 |
50 |
US |
III |
Hypertension, Proteinuria |
250 |
20 |
US |
III |
Post On PCABS |
2990 |
150 |
N. America, Europe |
II |
Proteinuria, Hypertension, Type 2 Diabetes |
210 |
20 |
US |
IV |
Nephropathy, Hypertension, Type 2 Diabetes |
856 |
124 |
US, S. America, S. Africa, Europe |
II |
Proteinuria, Hypertension |
50 |
4 |
US |
II |
CKD, Anemia |
114 |
19 |
US |
II |
CKD, Anemia |
20 |
2 |
US |
IV |
Microalbuminuria, Hypertension, Type 2 Diabetes |
400 |
90 |
N. America, Europe, S. Africa |
II |
CKD without dialysis, Anemia |
134 |
23 |
US |
I |
CKD |
63 |
5 |
US |
II |
CKD, Proteinuria, Type 2 Diabetes |
160 |
45 |
US |
IIIb |
Autosomal Dominant Polycystic Kidney Disease (ADPKD) |
2100 |
236 |
Europe, N. America, S. America |
IIa |
Secondary Hyperparathyroidism |
12 |
1 |
US |
IIb |
Secondary Hyperparathyroidism |
60 |
15 |
US |
II |
Diabetic nephropathy |
170 |
40 |
US |